The invention describes CD44-selective nanovector systems for cancer-targeted delivery of molecular therapeutics.
A novel hair growth-enhancing formulation for the treatment of male pattern baldness (androgenic alopecia).
This invention is a system to deliver poorly permeable molecules into mammalian cells and avoid the problem of degradation.
This invention is a novel composition of matter that facilitates delivery of agents (e.g. diagnostic, therapeutic, imaging, etc.) into cells
This invention utilizes a delivery system that allows for a biologically relevant moiety to be delivered to a desired cell by utilizing a transporting agent that binds two receptors expressed by that cell. This decreases the toxicity that is shown by the active compound by delivering it only to a targeted cell.
This invention is a novel composition of matter that disrupts endosomes allowing for the release of biologically active agents into the cytosol.
This innovation has two forms: a hard capsule that dissolves orally and a film that dissolves orally. The capsules can be filled with a drug formulation containing an active drug or drugs, excipients, and flavors.